Clinical Trials Logo

Clinical Trial Details — Status: Completed

Administrative data

NCT number NCT02656719
Other study ID # 2014-1
Secondary ID
Status Completed
Phase N/A
First received
Last updated
Start date August 2015
Est. completion date September 2016

Study information

Verified date March 2020
Source Tepecik Training and Research Hospital
Contact n/a
Is FDA regulated No
Health authority
Study type Interventional

Clinical Trial Summary

Trial is a randomized study to compare between ultrasound guided percutaneous tracheostomy and bronchoscopy guided percutaneous tracheostomy.


Description:

Trial is a randomized study to compare between ultrasound guided percutaneous tracheostomy and bronchoscopy guided percutaneous tracheostomy.

Patients will be randomly assigned to be submitted to evaluate safety, complication rates, easy to perform , clinical outcomes and effectivity.


Recruitment information / eligibility

Status Completed
Enrollment 80
Est. completion date September 2016
Est. primary completion date September 2016
Accepts healthy volunteers No
Gender All
Age group 18 Years and older
Eligibility Inclusion Criteria:

- All intubated and mechanically ventilated patients indicated for a tracheostomy

Exclusion Criteria:

- Patients with tracheal or neck abnormalities, soft tissue infection in the neck, neck surgery history, oxygenation problems , coagulation disorders or coagulation parameter changes and those requiring urgent or surgery patients unable to provide informed consent.

Study Design


Related Conditions & MeSH terms


Intervention

Device:
Ultrasound guided percutaneous tracheostomy
Ultrasound guided percutaneous tracheostomy
Bronchoscopy guided percutaneous tracheostomy
Bronchoscopy guided percutaneous tracheostomy

Locations

Country Name City State
n/a

Sponsors (2)

Lead Sponsor Collaborator
Aykut Saritas Prof.Dr.A.Ilhan Özdemir State Hospital

References & Publications (3)

Flint AC, Midde R, Rao VA, Lasman TE, Ho PT. Bedside ultrasound screening for pretracheal vascular structures may minimize the risks of percutaneous dilatational tracheostomy. Neurocrit Care. 2009 Dec;11(3):372-6. doi: 10.1007/s12028-009-9259-z. Epub 2009 Aug 13. — View Citation

Gobatto AL, Besen BA, Tierno PF, Mendes PV, Cadamuro F, Joelsons D, Melro L, Park M, Malbouisson LM. Comparison between ultrasound- and bronchoscopy-guided percutaneous dilational tracheostomy in critically ill patients: a retrospective cohort study. J Crit Care. 2015 Feb;30(1):220.e13-7. doi: 10.1016/j.jcrc.2014.09.011. Epub 2014 Sep 22. — View Citation

Ravi PR, Vijay MN. Real time ultrasound-guided percutaneous tracheostomy: Is it a better option than bronchoscopic guided percutaneous tracheostomy? Med J Armed Forces India. 2015 Apr;71(2):158-64. doi: 10.1016/j.mjafi.2015.01.013. Epub 2015 Mar 12. — View Citation

Outcome

Type Measure Description Time frame Safety issue
Other Hypoxemia Drop in peripheral oxygen saturation < 90% for more than 2 minutes as measured by pulse oximeter during the procedure During percutaneous tracheostomy an expected average of 20 minutes
Primary procedure failure of ultrasound to provide this anatomical information and ease of perform occurence of a major complications: bleeding, subcutaneous emphysema, oesophageal perforation, number of applied needle interventions, procedure duration, cardiorespiratory arrest During percutaneous tracheostomy an expected average time 20 minutes
Secondary procedure time the procedure duration was taken as the time that elapsed from the placement of the needle to the placement of the tracheostomy cannula. during percutaneous tracheostomy ( average expected time 20 minutes)
Secondary Pneumothorax Pneumothorax due to the percutaneous tracheostomy detected by clinical examination during the procedure or chest x-ray after the procedure. Participants will be followed for the duration of hospital stay, an expected average of 4 weeks
Secondary Tracheal posterior wall injury Tracheal posterior wall injury as detected by bronchoscopy after the procedure Participants will be followed for the duration of hospital stay, an expected average of 4 weeks
Secondary Accidental decannulation Accidental decannulation after the procedure during Hospital stay Participants will be followed for the duration of hospital stay, an expected average of 4 weeks
Secondary Cardiorespiratory arrest Cardiorespiratory arrest due to percutaneous tracheostomy during percutaneous tracheostomy an expected average of 20 minutes
Secondary Minor bleeding Haemorrhage that could not be stopped by sponge wrapping the stoma after the procedure and/or blood coming with aspiration inside the tracheostomy tube was defined as minor bleeding Participants will be followed for the duration of hospital stay, an expected average of 4 weeks
Secondary Major bleeding Continuous haemorrhage from the stoma and/or from the trachea with aspiration despite compresses was defined as a major haemorrhage. During the procedure an expected average of 20 minutes
See also
  Status Clinical Trial Phase
Completed NCT01502657 - Ultrasound Guided Percutaneous Tracheostomy N/A
Completed NCT02084862 - Ultrasound Guided Percutaneous Tracheostomy Compared to Bronchoscopy Guided Percutaneous Tracheostomy N/A